Skip to Main Content

Paper Details

HLA-B*14:02-Restricted Env-Specific CD8<sup>+</sup> T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.
J Virol
14
2017
CD8, CD8+, CD8+ T-Cell, CD8+ T-cell, CTL, EL9, ERYLKDQQL, Env, Gag, Gag-specific CTL, HIV, HIV disease, HLA, HLA-B*, HLA-B*14, HLA-B*14 subtype, HLA-B*14-DA9, HLA-B*14-EL9, HLA-B*14-restricted anti-HIV, HLA-B*14/, HLA-B*14:01, HLA-B*14:02, HLAs, cytotoxic T lymphocytes, human immunodeficiency virus type 1, human immunodeficiency virus type 1 (HIV), saporin
Author NameAffiliation
S??ren BuusUniversity of Copenhagen
David W HaasVanderbilt University School of Medicine
David W HaasVanderbilt University School of Medicine
Jacques FellayEcole Polytechnique Federale de Lausanne
Alicja TrochaRagon Institute of MGH
Alicja TrochaRagon Institute of MGH
Bruce D WalkerRagon Institute of MGH
Bruce D WalkerThe Doris Duke Medical Research Institute, University of KwaZulu-Natal
Bruce D WalkerRagon Institute of MGH
Bruce D WalkerThe Doris Duke Medical Research Institute, University of KwaZulu-Natal
Jeffrey N MartinUniversity of California San Francisco Department of Epidemiology and Biostatistics, University of California San Francisco
Steven G DeeksUniversity of California san francisco
Steven G DeeksUniversity of California san francisco
Steven M WolinskyUniversity of Oxford
Steven M WolinskyNorthwestern University Feinberg School of Medicine
Ying QiFrederick National Laboratory for Cancer Research
Otto O YangGeffen School of Medicine, University of California Los Angeles
Otto O YangAIDS Healthcare Foundation
Mary CarringtonRagon Institute of MGH
Mary CarringtonFrederick National Laboratory for Cancer Research
Mary CarringtonRagon Institute of MGH
Mary CarringtonFrederick National Laboratory for Cancer Research
  • 1 - 22

Datasets

Release 1.2